The goal of our program is to improve the lives of all people living with type 1 diabetes (T1D). Working closely with key players across the T1D ecosystem – patients, physicians, caregivers, researchers, government agencies, funders, pharmaceutical companies, device makers, insurers, and community organizations – we seek to improve care and ultimately prevent the disease.
COVID-19 Update: April 20, 2020
People living with severe, chronic diseases like type 1 diabetes are at greater risk of poor outcomes from COVID-19. Staying healthy is essential, but also more challenging right now due to more limited mobility, stock-outs of some needed supplies, and the financial impacts of COVID-19 that so many people are facing. Our position is clear: nobody should ever be without insulin, access to healthcare experts, or supplies to manage diabetes – especially now. We are in touch with grantees around the world, and in rapid response mode. In the United States, we are in the process of awarding more than 50 grants for clinical care and to facilitate distribution of insulin and necessary supplies.
Many of these grants will make it newly possible for people with type 1 diabetes to receive expert care remotely by rapidly scaling telehealth. This is an urgent priority and a near-term investment that will serve the community well once the current crisis is over.
Resources from Partners in the Type 1 Diabetes Field:
can a type ii diabetic do the keto diet breakfast recipes (🔴 mellitus without complication) | can a type ii diabetic do the keto diet diet ukhow to can a type ii diabetic do the keto diet for https://www.diabetesdisasterresponse.org/
can a type ii diabetic do the keto diet knowledge portal (🔴 beta cells) | can a type ii diabetic do the keto diet genetics naturehow to can a type ii diabetic do the keto diet for